Table 1 |
|||||||
|
Study procedures at various stages of the AVEC trial |
|||||||
|
Visit |
Screen |
Enrollment |
Baseline |
Titrate* |
Follow-up |
||
|
|
|||||||
|
Months |
0 |
2-4 weeks |
1 |
2-3 |
3 |
6 |
12 |
|
|
|||||||
|
Informed Consent/Eligibility |
X |
X |
X |
||||
|
|
|||||||
|
Medication Inventory |
X |
X |
X |
X |
X |
X |
|
|
|
|||||||
|
Weight/Height |
X |
X |
X |
||||
|
|
|||||||
|
Blood pressure (2 every 5 min) |
X |
X |
X |
X |
X |
X |
X |
|
|
|||||||
|
Psychological Assessment |
X |
X |
X |
X |
|||
|
|
|||||||
|
Cerebrovascular Assessment |
X |
X |
X |
||||
|
|
|||||||
|
Biochemical Measures |
X |
X |
X |
X |
X |
||
|
|
|||||||
|
Renin/Aldosterone |
X |
X |
X |
||||
|
|
|||||||
|
Adverse Events Screening |
X |
X |
X |
X |
|||
|
|
|||||||
|
If a titration of medication needed baseline will be performed after titration and before randomization |
|||||||
|
Hajjar et al. BMC Geriatrics 2009 9:48 doi:10.1186/1471-2318-9-48 |
|||||||